PHESGO
-
Roche India launched PHESGO, therapy for breast cancer
The first ever fixed dose formulation in oncology to combine two monoclonal antibodies – Perjeta (pertuzumab) and Herceptin Roche Pharma…
Read More »
The first ever fixed dose formulation in oncology to combine two monoclonal antibodies – Perjeta (pertuzumab) and Herceptin Roche Pharma…
Read More »